These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9621196)

  • 1. Campylobacter jejuni strains from patients with Guillain-Barré syndrome.
    Allos BM; Lippy FT; Carlsen A; Washburn RG; Blaser MJ
    Emerg Infect Dis; 1998; 4(2):263-8. PubMed ID: 9621196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.
    Lastovica AJ; Goddard EA; Argent AC
    J Infect Dis; 1997 Dec; 176 Suppl 2():S139-43. PubMed ID: 9396698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiologic approaches for studying Campylobacter species in patients with Guillain-Barré syndrome.
    Nachamkin I
    J Infect Dis; 1997 Dec; 176 Suppl 2():S106-14. PubMed ID: 9396692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
    Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
    J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome.
    Saida T; Kuroki S; Hao Q; Nishimura M; Nukina M; Obayashi H
    J Infect Dis; 1997 Dec; 176 Suppl 2():S129-34. PubMed ID: 9396696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
    Prendergast MM; Lastovica AJ; Moran AP
    Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
    Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
    Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
    Takahashi M; Koga M; Yokoyama K; Yuki N
    J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between pathogenesis of Guillain-Barre syndrome and Penner's serotypes of Campylobacter jejuni.
    Li H; Yuan J; Shen B; Sun X; Hao H
    Chin Med J (Engl); 1999 Sep; 112(9):794-6. PubMed ID: 11717947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Campylobacter infection and Guillain-Barré syndrome.
    Allos BM
    J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Campylobacter jejuni/C.coli infection in patients with Guillain-Barré syndrome by serology and culture.
    Hariharan H; Naseema K; Kumaran C; Shanmugam J; Nair MD; Radhakrishnan K
    New Microbiol; 1996 Jul; 19(3):267-71. PubMed ID: 8841044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
    Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
    Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis.
    Engberg J; Nachamkin I; Fussing V; McKhann GM; Griffin JW; Piffaretti JC; Nielsen EM; Gerner-Smidt P
    J Infect Dis; 2001 Jul; 184(2):215-20. PubMed ID: 11400076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome.
    Mishu B; Blaser MJ
    Clin Infect Dis; 1993 Jul; 17(1):104-8. PubMed ID: 8353228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome.
    Fujimoto S; Yuki N; Itoh T; Amako K
    J Infect Dis; 1992 Jan; 165(1):183. PubMed ID: 1727892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
    Ihara Y; Saito K; Yoshimoto S; Hayabara T; Yuki N
    Rinsho Shinkeigaku; 1995 Aug; 35(8):901-3. PubMed ID: 8665735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter jejuni infection and Guillain-Barré syndrome.
    Rees JH; Soudain SE; Gregson NA; Hughes RA
    N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.